Market Place
Sourcing Support
FDA Approves Almirall`s Klisyri For Expanded Actinic Keratosis Treatment
10 Jun 2024 //
BUSINESSWIRE
Almirall’s Klisyri approved to treat larger actinic keratosis areas
10 Jun 2024 //
PHARMACEUTICAL TECHNOLOGY
Almirall`s Klisyri receives strong recommendation in AAD AK guideline update
18 Aug 2022 //
PRNEWSWIRE
Almirall launches Klisyri for the treatment of actinic keratosis in Europe
27 Sep 2021 //
YAHOO
Almirall`s Klisyri (tirbanibulin) Receives Approval in Europe
16 Jul 2021 //
EMA
Almirall receives positive CHMP opinion for Klisyri®? (tirbanibulin)
21 May 2021 //
PRNEWSWIRE
Almirall U.S. Launches Klisyri® (tirbanibulin), a New, Innovative Topical
18 Feb 2021 //
PRNEWSWIRE
Athenex Announces New England Journal of Medicine Publication of Phase III
11 Feb 2021 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.